These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 6440496)

  • 1. [Accentuation of myocardial ischemia during coronary recanalization in the acute phase of myocardial infarction].
    Monassier JP; Valeix B; Guarino L; Hanssen M; Labrunie P; Coulbois PM; Touhami L; Roman S; Morand P; Gérard R
    Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1456-61. PubMed ID: 6440496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
    Wasilewski J; Osadnik T; Poloński L
    Kardiol Pol; 2006 Sep; 64(9):967-72; discussion 973-4. PubMed ID: 17054028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The late open artery hypothesis at the crossroad. The ACTOR study: aggressive versus conservative treatment of the infarct-related artery after acute MI. ACTOR Study Group.
    G Ital Cardiol; 1999 Jan; 29(1):1-10. PubMed ID: 9987041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
    Karmpaliotis D; Turakhia MP; Kirtane AJ; Murphy SA; Kosmidou I; Morrow DA; Giugliano RP; Cannon CP; Antman EM; Braunwald E; Gibson CM;
    Am J Cardiol; 2004 Nov; 94(9):1113-7. PubMed ID: 15518603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction.
    Syed MA; Borzak S; Asfour A; Gunda M; Obeidat O; Murphy SA; Gibbons RJ; Gourlay SG; Barron HV; Weaver WD; Hudson M
    Am Heart J; 2004 Feb; 147(2):275-80. PubMed ID: 14760325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of acute transmural myocardial infarction: a study on 200 patients admitted to a tertiary care medical center].
    Kassab R; Rachoin JS; Azar R; Salamé E
    J Med Liban; 2005; 53(1):2-8. PubMed ID: 16398206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
    Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
    J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction.
    Haude M; Schulz R; Heusch G; Erbel R
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):667-80. PubMed ID: 16076277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitation of infarct size with thrombolytic agents--electrocardiographic indexes.
    Goldberg S; Urban P; Greenspon A; Berger B; Walinsky P; Muza B; Kusiak V; Maroko PR
    Circulation; 1983 Aug; 68(2 Pt 2):I77-82. PubMed ID: 6861330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
    Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
    Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recording lead V(4)R is associated to enhanced use of fibrinolytic therapy in acute myocardial infarction.
    Harju JA; Eskola MJ; Huhtala H; Niemelä KO; Karhunen PJ; Nikus KC
    J Electrocardiol; 2006 Oct; 39(4):368.e1-5. PubMed ID: 16697401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The first non-Q myocardial infarct as a clinical manifestationn of acute coronary syndrome].
    Kovacević B; Potić M; Arsić M; Panić G; Jung R; Cemerlić-Adić N; Dejanović J; Stajnic M
    Med Pregl; 2001; 54(5-6):251-5. PubMed ID: 11759221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial revascularization in the developing phase of myocardial infarction using intracoronary thrombolytic therapy].
    Puel J; Miquel JP; Massabuau P; Cassagneau B; Miluau S; Fauvel JM; Bounnoure JP
    Rev Med Univ Navarra; 1984 Dec; 28(4):43-6. PubMed ID: 6528151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction].
    Yamamoto T; Katori R
    J Cardiol; 1995 Sep; 26(3):167-75. PubMed ID: 7473047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.